Pharmacy Practice in Focus: Health Systems May 2025 Volume 14 Issue 3 APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes Alana Hippensteele, Lead Editor Key Takeaways GLP-1 receptor agonists excel in stroke prevention, weight loss, and glycemic control, with significant reductions in major adverse cardiovascular events
It also examines the potential of peptides like Epithalon and DSIP in regulating circadian rhythms and improving sleep quality
You will notice a smooth texture and clear pores with time
L., McGowan, B., Mosenzon, O., Pedersen, S
It consists of a chain of 15 amino acids and was first investigated in research exploring gastric mucosal protection and tissue repair